Celltrion Sets Out Strategy For China

As Firm Announces Plans For A Biosimilar Launch Every Year

 
• By David Wallace
  
Wuhan
Celltrion Will Construct A Biologics Facility In Wuhan, China • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business